Inventor · disambiguated record
Niek Verweij
Also filed as: VERWEIJ NIEK
4 granted patents·5 pending applications·0 citations·filing 2021–2024
57Inventor score
Files withREGENERON PHARMA9
Top patents by PatentIndex Score
9 records- 0175US2024376471A1Treatment of Liver Diseases With Cell Death Inducing DFFA Like Effector B (CIDEB) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0273US2025188473A1Methods Of Treating Liver Diseases With Phosphodiesterase 3B (PDE3B) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0371US12018259B2Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitorsREGENERON PHARMA·Filed 2021·Granted Jun 25, 2024·0 cites·22 claims
- 0470US12123001B2Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitorsREGENERON PHARMA·Filed 2022·Granted Oct 22, 2024·0 cites·14 claims
- 0570US11773393B2Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitorsREGENERON PHARMA·Filed 2022·Granted Oct 3, 2023·0 cites·27 claims
- 0670US2025197866A1Treatment Of Liver Disease With Mitochondrial Glycerol-3-Phosphate Acyltransferase (GPAM) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0764US12215322B2Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitorsREGENERON PHARMA·Filed 2022·Granted Feb 4, 2025·0 cites·3 claims
- 0857US2023160012A1Treatment of Liver Diseases With CAMP Responsive Element Binding Protein 3 Like 3 (CREB3L3) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0954US2022307033A1Treatment Of Liver Disease With Ring Finger Protein 213 (RNF213) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Niek Verweij files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →